Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Research and Markets: Vaccine Market to 2019 - The Market is Expected to Reach $57.8 Billion by 2019 from $33.1 Billion in 2014

share with twitter share with LinkedIn share with facebook
share via e-mail
08/14/2015 | 04:50pm CEST

Research and Markets (http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019" report to their offering.

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. For the purposes of this report the global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Vaccines Market, By Technology

8 Vaccines Market, By Type

9 Vaccines Market, By Disease Indication

10 Vaccines Market, By End User

11 Global Vaccine Technology Market, By Region

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned

  • Bavarian Nordic
  • CSL Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, PLC.
  • Johnson & Johnson
  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.

For more information visit http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by

© Business Wire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Companies"
01:39aQUAD/GRAPHICS : New owners seek tenants for former Quad Graphics-Brown Printing facility
01:36aAMAZON COM : Five Kindle Direct Publishing Authors Win Top Romance Writing Award
01:34aMotion to Sanction for Evidence Spoliage Filed against Defendant Enterprise Holdings, SubscriberWise Confirms
01:28aDELTA OIL & GAS : Appoints Jordan P. Balencic, D.O. As Chief Compliance Officer
01:28aSEMPRA ENERGY : SoCalGas Helps Put the "Green" in Greenhouse with New Thermal Technology at World-Renowned Houweling's Tomatoes
01:26aCalSTRS Reports 9.0 Percent Net Investment Return for FY 17-18
01:25aMiramont Provides Cerro Hermoso Update
01:24aMIRT REOS : Miramont Provides Cerro Hermoso Update
01:18aCIBT EDUCATION : Confirms Subject Removal on the Sale of a GEC® Project for $55.5 Million
01:07aMAZDA MOTOR : Suspect in Westmoreland arson case arrested, car is linked to missing woman
Latest news "Companies"